BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  GSK Acquires Sierra in $1.9B Complimentary Deal Aimed at Rare Cancers

  GSK is acquiring Sierra Oncology for $1.9 billion in a deal expected to help both companies take a major step in developing a treatment for rare types of cancer.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  AACR Spotlight: Victoria’s Secret Awards 5 Female Cancer Researchers, AbbVie and More

  As the American Association of Cancer Research (AACR) Annual Meeting wraps up, there were some surprising and exciting research news and presentations.

  April 13, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  ProQR to Cut 30% of Workforce, CSO Following Unexpected Trial Failure

  ProQR Therapeutics, which is developing RNA therapies for genetic eye diseases, announced Wednesday that it will be restructuring and laying off 30% of its staff.

  April 13, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  CureDuchenne is Filling the Therapeutic Pipeline with Next Generation DMD Treatments

  Companies like Chameleon Biosciences and Code Biotherapeutics will present their latest research at the FUTURES 2022 conference hosted by CureDuchenne.

  April 13, 2022

   · 

  5 min read

   · 

  Abbey Glasure
• 

  Business

  Halozyme Picks Up Antares’ Drug Delivery Tech for Nearly $1B

  Halozyme Therapeutics announced that it is acquiring Antares Pharma for $960 million in cash. The news caused Antares stock to rocket 47% in premarket trading.

  April 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  9 Meters Scores Patent for Hyperphagia, Obesity-Fighting Drug

  9 Meters Biopharma has received notice from the U.S. Patent and Trademark Office (USPTO) allowing its patent for therapeutic NM-136 to treat hyperphagia (extreme hunger) and obesity.

  April 13, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Job Trends

  AbbVie, Others Spring Into New Real Estate, Personnel Investments

  With Spring comes new beginnings, and companies within the biopharmaceutical industry are blossoming with fresh ventures. Here are some of them:

  April 13, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  COVID-19: New Subvariant Gains Traction and Hopeful News for the Immunocompromised

  As the world speculates the potential impact of the novel COVID-19 variant omicron XE and subvariant BA.2, research continues to shed light on the impact and future of the pandemic.

  April 13, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Business

  Money on the Move: April 6-13

  Companies working on cell therapies got most of the funding in the life sciences venture capital world this week. For that and more, continue reading.

  April 13, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  BioCapital

  Gain’s Parkinson’s Asset Generates Excitement in Early Research

  Gain Therapeutics’ candidate compound for Parkinson’s Disease demonstrated the ability to increase GCase protein levels and enhance neuronal activity.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN